Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents
Clinical trial NCT02636192 · COMPLETED
Trial details
- NCT number
- NCT02636192
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-31
- Primary completion
- 2017-04-07
- Enrollment
- 200000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.